U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
141301141301A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057Active, not recruitingNo Results AvailableSystemic Lupus ErythematosusDrug: belimumabhttps://ClinicalTrials.gov/show/NCT00712933
141302141302A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial AllergiesCompletedHas ResultsPerennial Allergic RhinitisDrug: 0.15% azelastine hydrochloride|Drug: 0.1% azelastine hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00712920
141303141303Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood FlowCompletedNo Results AvailableOcular Physiology|Regional Blood FlowDietary Supplement: vitamin C (Mayrhofer) 24mg/min i.v. for 64 min|Dietary Supplement: Placebo|Other: 100% O2 (AGA) two times for 12 minhttps://ClinicalTrials.gov/show/NCT00712907
141304141304Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial InfarctionCompletedNo Results AvailableAcute Myocardial Infarction|Percutaneous Coronary InterventionDrug: Diltiazem|Drug: Verapamil|Drug: Nitroglycerinhttps://ClinicalTrials.gov/show/NCT00712894
141305141305Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Patients With HER2-Positive Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: MYOCET® Plus Cyclophosphamide and Trastuzumab, 4 cycles, followed by Docetaxel plus Trastuzumab, 4 cycles|Drug: Free Doxorubicin Plus Cyclophosphamide, 4 cycles, followed by Docetaxel plus Trastuzumab, 4 cycleshttps://ClinicalTrials.gov/show/NCT00712881
141306141306Acceptability of Lactacyd FeminaCompletedNo Results AvailableHygieneDrug: Lactic acidhttps://ClinicalTrials.gov/show/NCT00712868
141307141307A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaBiological: mapatumumab|Drug: sorafenibhttps://ClinicalTrials.gov/show/NCT00712855
141308141308Neurovascular Coupling in Patients With Early Stage Diabetes RetinopathyCompletedNo Results AvailableDiabetic RetinopathyOther: Ocular blood flow measurementshttps://ClinicalTrials.gov/show/NCT00712842
141309141309Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging AgentsCompletedNo Results AvailableProstate CancerDrug: 123-I-MIP-1072|Drug: 123-I-MIP-1095https://ClinicalTrials.gov/show/NCT00712829
141310141310Use of Cold and Compression Therapy With Total Knee Replacement PatientsActive, not recruitingNo Results AvailableOsteoarthritis|Total Knee ArthroplastyDevice: Game Ready Injury Treatment System (CoolSystems Inc.)|Other: Ice with compressive bandageshttps://ClinicalTrials.gov/show/NCT00712816
141311141311Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy AdultsCompletedNo Results AvailableDengueBiological: rDEN3-3'D4delta30|Biological: rDEN3-3'D4delta30|Biological: rDEN3-3'D4delta30https://ClinicalTrials.gov/show/NCT00712803
141312141312Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)Active, not recruitingNo Results AvailableHepatocellular CarcinomaDrug: Sorafenib|Radiation: SIR-Sphereshttps://ClinicalTrials.gov/show/NCT00712790
141313141313Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor PolymorphismWithdrawnNo Results AvailableOcular Physiology|Intraocular PressureDrug: Brimonidine 0.2 %https://ClinicalTrials.gov/show/NCT00712777
141314141314Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure.CompletedNo Results AvailableOcular Physiology|MicrocirculationDrug: Adenosine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00712764
141315141315The Sexual Health of Rectal Cancer PatientsActive, not recruitingNo Results AvailableRectal Cancer|RectumBehavioral: questionnaires|Behavioral: CSI-SH- Cancer Survivorship Interventionhttps://ClinicalTrials.gov/show/NCT00712751
141316141316Oral Nifedipine to Treat Iron OverloadCompletedNo Results AvailableThalassemia|Iron Overload|HemochromatosisDrug: Nifedipine|Procedure: Phlebotomy|Procedure: Urinalysis|Procedure: Echocardiogram|Procedure: Electrocardiogramhttps://ClinicalTrials.gov/show/NCT00712738
141317141317MK3207 for Treatment of Acute Migraines (3207-005)CompletedHas ResultsMigraineDrug: MK3207- 2.5 mg|Drug: MK3207- 5 mg|Drug: MK3207- 10 mg|Drug: MK3207- 20 mg|Drug: MK3207- 50 mg|Drug: MK3207- 100 mg|Drug: Comparator: placebo (unspecified)https://ClinicalTrials.gov/show/NCT00712725
141318141318Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With CancerRecruitingNo Results AvailableMetastatic Cancer|Pain|Unspecified Adult Solid Tumor, Protocol SpecificDrug: acetaminophen|Drug: morphine sulfate|Other: questionnaire administration|Procedure: quality-of-life assessment|Procedure: radiofrequency ablationhttps://ClinicalTrials.gov/show/NCT00712712
141319141319Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHDCompletedNo Results AvailableAttention Deficit Disorder With HyperactivityDrug: Sequence 1: XR-MAS then placebo|Drug: Sequence 2 Placebo then XR-MAShttps://ClinicalTrials.gov/show/NCT00712699
141320141320Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Aripiprazole|Drug: Olanzapinehttps://ClinicalTrials.gov/show/NCT00712686
141321141321GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Lixisenatide (AVE0010)|Drug: Placebo|Device: Pen auto-injector|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT00712673
141322141322Study With Information Technology (IT) - Aided Preventive Program in SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: antipsychotic dose increase|Other: no interventionhttps://ClinicalTrials.gov/show/NCT00712660
141323141323Carotene and Retinol Efficacy TrialCompletedNo Results AvailableLung CancerDrug: Beta Carotene and Retinol|Other: Placebohttps://ClinicalTrials.gov/show/NCT00712647
141324141324Cytomegalovirus Vaccine in Healthy ParticipantsCompletedNo Results AvailablePrecancerous/Nonmalignant ConditionBiological: CMVpp65-A*0201 peptide vaccinehttps://ClinicalTrials.gov/show/NCT00712634
141325141325Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or CombinationWithdrawnNo Results AvailableBreast CarcinomaBehavioral: Counseling|Behavioral: Written materialshttps://ClinicalTrials.gov/show/NCT00712621
141326141326The Evaluation of Cow's Milk Formula - Study BCompletedNo Results AvailableHealthy Term InfantsOther: Infant formula|Other: Infant formula|Other: Cow's milk infant formulahttps://ClinicalTrials.gov/show/NCT00712608
141327141327Mifepristone for Treatment of Uterine FibroidsCompletedNo Results AvailableUterine FibroidsDrug: Mifepristone|Drug: Mifepristonehttps://ClinicalTrials.gov/show/NCT00712595
141328141328Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell LymphomaActive, not recruitingNo Results AvailableNon-Hodgkin's LymphomaDrug: Etoposide, carboplatin, ifosfamide|Drug: Rituximab, Ifosfamide, Etoposide, Carboplatin|Drug: Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustinehttps://ClinicalTrials.gov/show/NCT00712582
141329141329Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and AnxietyCompletedNo Results AvailableBreast CancerBehavioral: questionnaires|Behavioral: audio recordings , questionnaires|Behavioral: audio recorded questionnaireshttps://ClinicalTrials.gov/show/NCT00712569
141330141330PET Study in Patients With Non-Hodgkin LymphomaCompletedNo Results AvailableLymphomaRadiation: fluorine 18-fludeoxyglucose positron emission tomographyhttps://ClinicalTrials.gov/show/NCT00712556

* Görseller ve İçerik tekif hakkına sahip olabilir